Oxidative stress, inflammation, and peritoneal dialysis: A molecular biology approach
Georgie Innico,Laura Gobbi,Giovanni Bertoldi,Matteo Rigato,Anna Basso,Luciana Bonfante,Lorenzo A. Calò
DOI: https://doi.org/10.1111/aor.14001
2021-06-15
Artificial Organs
Abstract:<p>The key role of oxidative stress (OxSt) and inflammation for the induction of cardiovascular disease, the leading cause of excess morbidity/mortality in chronic kidney disease and dialysis patients, is known and both the activation of NADPH oxidase and RhoA/Rho kinase (ROCK) pathway are pivotal for their effects. While specific hemodialysis procedures, such as hemodiafiltration with on-line reinfusion of ultrafiltrate and/or the use of vitamin E coated dialyzers, are beneficial on OxSt and inflammation, studies in peritoneal dialysis (PD) are instead scarce and results seem not favorable.</p><p>In nine patients under PD OxSt in terms of mononuclear cell protein level of p22<sup>phox</sup> (Western blot), subunit of NADPH oxidase, essential for the generation of OxSt, and MYPT-1 phosphorylation state (Western blot), a marker of ROCK activity, have been measured at the beginning and after 3 and 6 months of PD. Blood levels of Interleukin 6 (IL-6), Ferritin and Albumin have been considered for evaluating the inflammatory state.</p><p>p22<sup>phox</sup> protein expression, MYPT-1-phosphorylation, and ferritin level were increased both at baseline vs healthy subjects (p=0.02, p<0.0001, p=0.004 respectively) and vs baseline after 3 and 6 months of peritoneal dialysis (p=0.007, p<0.001, p=0.004 respectively). Albumin was lower after 6 months of PD (p=0.0014). IL-6 was increased at baseline vs reference values and remained unchanged at 3 and 6 months.</p><p>OxSt and inflammation increase during PD confirming via molecular biology approach a report at biochemical level. To improve OxSt state in PD, a multitarget approach is necessary. It might include the use of more physiologic pH, low glucose degradation products, low lactate and iso-osmolar PD solutions, patients' strict glycemic control, optimal volume management and antioxidants administration, such as N-acetylcysteine.</p>
engineering, biomedical,transplantation